Member Info for JohnHenry

Noooo. Foralumab (TZLS-401 / NI-0401) is the crown jewels.

Swerves you do know what an NDA is ????

As a trader waiting for the 117.5p break and retest will know doubt set up for a possible 160p target.

However as an Investor its utter nonsense.

I would imagine Nobby is investing on Margin so requires a little more comfort. However its support areas one should be concentrating on,

I find his Logic very ODD

Yes 2X 40K a few bedwetters at 110p to clear.

Only PEEL on at 115p 40k live buy full ask.

Defo PEEL moved offer 115p

Clearing overhang ???

Chart is looking great and breaking out from a large wedge formation.

Once the 105p bedwetters depart SP should spike to 120p

I also believe that the record date for the Stemprimer list will be the date of the announcement. Traders and investors waiting for an announcement and future date will be locked out.

Mana, overhang and bedwetters need to depart before a strong move. aimho

£21 million cash has come our way, how do you make that out ?????/

Helps if you understand market pricing cycles, Companies will carry much higher valuations during the speculative, hype phase. NCYT has been rerated down from the speculative phase to the earnings valuation phase. ODX GDR are still in that hype phase. Aimho

£5 a share is possible however they need to be making over £300 million in sales. Aimho

Imho Market will price Covid testing stocks on secured sales. Hence valuation for NCYT around £150M. ODX, GDR still carrying a speculative rating and will be derated once sales come through and priced accordingly.

LOL ive always been positive and have initial holdings from 43p. However i sometimes comment on short term negatives such as overhangs techs etc

Investors selling now must be nuts imho, traders and bedwetters they can sell and move on.

Very very significant news.

Offer under Mid would indicate supply is very much still in the Market. FINNCAP are F ing useless.

Nah book is fairly balanced, supply and demand equal, volume is pretty poor considering the excellent news.

At present very little investor interest in NCYT.

Markets are about supply and demand, at present to much supply from the overhang. Not enough demand, when demand picks up and clears the overhang, price will move higher.

Quite simple.